Latest On Brainsway Ltd (BRSYF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 02:59 EST | News | BrainsWay Q1 2023 Results: A Step In The Right Direction | N/A |  |
| 2023-05-17 13:20 EST | News | BrainsWay Ltd. (BWAY) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-03-15 22:33 EST | News | BrainsWay Ltd. (BWAY) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-18 02:03 EST | News | Why I Am Passing On BrainsWay And Neuronetics | N/A | |
| 2022-11-17 00:06 EST | News | Brainsway GAAP EPS of -$0.15 misses by $0.09, revenue of $5.17M misses by $3.28M | N/A | |
| 2022-11-17 00:06 EST | News | BrainsWay Ltd. (BWAY) Q3 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-11 05:08 EST | News | BrainsWay Ltd.'s (BWAY) CEO Christopher von Jako on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-26 06:02 EST | News | Brainsway (BWAY) Investor presentations - Slideshow | N/A | |
| 2022-05-11 17:49 EST | News | BrainsWay's (BWAY) CEO Chris von Jako on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-03-09 18:53 EST | News | BrainsWay's (BWAY) CEO Christopher von Jako on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-18 08:50 EST | News | BrainsWay Ltd. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-18 08:50 EST | News | BrainsWay Ltd. (BWAY) CEO Christopher von Jako on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-09-22 19:27 EST | News | Brainsway (BWAY ) Investor Presentation - Slideshow | N/A | |
| 2021-08-11 15:17 EST | News | BrainsWay Ltd. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-11 15:17 EST | News | BrainsWay Ltd.'s (BWAY) CEO Christopher von Jako on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-03-26 03:43 EST | News | BrainsWay's (BWAY) CEO Christopher von Jako on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-18 06:50 EST | Earnings Estimate | An EPS average of -$0.07 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-12-04 06:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 01:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-20 07:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-19 08:55 EST | News | Brainsway Ltd. (BWAY) CEO Chris von Jako on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-10-08 21:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-15 03:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 03:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-13 09:32 EST | News | BrainsWay Ltd. (BWAY) CEO Christopher von Jako on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-06 16:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 15:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-07 03:20 EST | Earnings Estimate | An EPS average of -$0.08 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-07-03 07:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 07:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-29 23:23 EST | Earnings Estimate | An EPS average of -$0.24 is estimated for the 2021 year. | Sell | |
| 2020-06-29 23:23 EST | Earnings Estimate | An EPS average of -$0.46 is estimated for the 2020 year. | Sell | |
| 2020-06-29 23:23 EST | Analyst Rating | The Analyst Target Price has increased from $0 to $13. | Buy | |
About Brainsway Ltd (BRSYF):
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
General
- Name Brainsway Ltd
- Symbol BRSYF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 107
- Fiscal Year EndDecember
- Web URLhttp://www.brainsway.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 4.27
- Price/Book (Most Recent Quarter) 6.46
- Enterprise Value Revenue 5.84
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.05
- Profit Margin -34%
- Operating Margin -25%
- Return on Assets -9%
- Return on Equity -32%
- Revenue 21.28 million
- Earnings Per Share -$0.51
- Revenue Per Share $1.04
- Gross Profit 19.16 million
- Quarterly Earnings Growth 1.4%
View More
Highlights
- Market Capitalization 140.08 million
- EBITDA -4924000
- Analyst Target Price $13
- Book Value Per Share $0.89
View More
Share Statistics
- Shares Outstanding 31.76 million
- Shares Float 12.51 million
- % Held by Insiders 2493%
- % Held by Institutions 15.78%
View More
Technicals
- Beta 0.64
- 52 Week High $5.03
- 52 Week Low $2.55
- 50 Day Moving Average 4.05
- 200 Day Moving Average 3.32
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Brainsway Ltd (BRSYF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Brainsway Ltd (BRSYF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-18 | $N/A | -$0.04 | -$0.04 | 0% |
| 2020-06-30 | 2020-09-30 | $4.82 million | -$0.04 | -$0.11 | 63.64% |
| 2020-03-31 | 2020-06-30 | $4.16 million | -$0.03 | -$0.15 | 80% |
| 2019-12-31 | 2020-03-31 | $6.29 million | -$0.15 | -$0.12 | -25% |
| 2019-09-30 | 2019-12-31 | $5.93 million | -$0.10 | -$0.14 | 28.57% |
| 2019-06-30 | 2019-09-30 | $5.7 million | -$0.12 | -$0.12 | 0% |
| 2019-03-31 | 2019-06-30 | $5.18 million | -$0.17 | -$0.13 | -30.77% |
| 2018-12-31 | 2019-03-31 | $4.77 million | -$0.11 | ||
| 2018-09-30 | 2018-12-31 | $4.3 million | -$0.15 | ||
| 2018-06-30 | 2018-09-30 | $3.73 million | -$0.09 | ||
| 2018-03-31 | 2018-06-30 | $3.61 million | -$0.12 | ||
| 2017-12-31 | 2018-03-31 | $3.6 million | -$0.06 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $3.02 million | -$0.19 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $2.38 million | -$0.12 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $2.15 million | -$0.03 | ||
| 2016-12-31 | 2017-03-31 | $2.88 million | -$0.13 | ||
| 2016-09-30 | 2016-12-31 | -$0.12 | |||
| 2016-06-30 | 2016-09-30 | -$0.04 | |||
| 2016-03-31 | 2016-06-30 | $0.06 | |||
| 2015-12-31 | 2016-03-31 | -$0.07 | |||
| 2015-09-30 | 2015-12-31 | -$0.11 | |||
| 2015-06-30 | 2015-09-30 | -$0.02 | |||
| 2015-03-31 | 2015-06-30 | -$0.05 | |||
| 2014-12-31 | 2015-03-31 | -$0.10 | |||
| 2014-09-30 | 2014-12-31 | -$0.24 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | -$0.05 | |||
| 2014-03-31 | 2014-06-30 | -$0.06 | |||
| 2013-12-31 | 2014-03-31 | -$0.25 | |||
| 2013-09-30 | 2013-12-31 | -$0.01 | |||
| 2013-06-30 | 2013-09-30 | -$0.08 | |||
| 2013-03-31 | 2013-06-30 | -$0.05 | |||
| 2012-12-31 | 2013-03-31 | -$0.42 | |||
| 2012-09-30 | 2012-12-31 | -$0.17 | |||
| 2012-06-30 | 2012-09-30 | -$0.11 | |||
| 2012-03-31 | 2012-06-30 | -$0.04 | |||
| 2011-12-31 | 2012-03-31 | -$0.15 | |||
| 2011-09-30 | 2011-12-31 | -$0.12 | |||
| 2011-06-30 | 2011-09-30 | -$0.10 | |||
| 2011-03-31 | 2011-06-30 | -$0.24 | |||
| 2010-12-31 | 2011-03-31 | -$0.11 | |||
| 2010-09-30 | 2010-12-31 | -$0.47 | |||
| 2010-06-30 | 2010-06-30 | $0.50 | |||
| 2010-03-31 | 2010-03-31 | -$0.72 | |||
| 2009-12-31 | 2009-12-31 | $0.40 | |||
| 2009-09-30 | 2009-09-30 | $0.32 |
Brainsway Ltd (BRSYF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 1.04 million | 1.8 million | 1.81 million | 1.91 million |
| Income Before Tax | N/A | -394000 | -3.31 million | -2.17 million | -2.52 million |
| Selling General Administrative | N/A | 3 million | 4.97 million | 1.72 million | 5.04 million |
| Gross Profit | N/A | 3.83 million | 3.14 million | 4.85 million | 4.78 million |
| Ebit | N/A | 360000 | -2.88 million | -2.36 million | -1.46 million |
| Operating Income | N/A | -215000 | -3.62 million | -1.99 million | -2.18 million |
| Income Tax Expense | 170000 | 177000 | 130000 | 147000 | 113000 |
| Total Revenue | N/A | 4.82 million | 4.16 million | 6.29 million | 5.93 million |
| Cost of Revenue | N/A | 992000 | 1.02 million | 1.44 million | 1.15 million |
| Total Other Income Expense Net | N/A | N/A | N/A | -1.37 million | -344000 |
| Net Income From Continuing Operations | N/A | -571000 | -3.44 million | -2.32 million | -2.63 million |
| Net Income Applicable to Common Shares | -966000 | -571000 | -3.44 million | -2.32 million | -2.63 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | -968000 | N/A | -396000 | -1.22 million |
| Change to Liabilities | -664000 | N/A | -428000 | 285000 | -449000 |
| Total Cash Flow from Investing Activities | -646000 | N/A | -936000 | -396000 | -1.22 million |
| Net Borrowings | -101000 | N/A | -110000 | -123000 | -104000 |
| Total Cash Flow from Financial Activities | N/A | -111000 | N/A | -414000 | -363000 |
| Change to Operating Activities | 673000 | N/A | 338000 | -5000 | 322000 |
| Change in Cash | N/A | -356000 | N/A | -2.07 million | -3.67 million |
| Total Cash from Operating Activities | -1.12 million | 616000 | -2.58 million | -1.23 million | -2.06 million |
| Depreciation | N/A | 575000 | N/A | 659000 | 711000 |
| Other Cash Flow from Investing Activities | -2000 | N/A | 10000 | -22000 | 1.01 million |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | 270000 | N/A | -469000 | -637000 |
| Other Cash Flow from Financing Activities | N/A | N/A | 42000 | -291000 | -259000 |
| Change to Net Income | 362000 | N/A | 128000 | 1.81 million | 625000 |
| Capital Expenditures | N/A | 965000 | N/A | 338000 | 1.19 million |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 14.55 million | N/A | 14.52 million | 14.59 million |
| Total Stockholder Equity | N/A | 20.64 million | N/A | 24.22 million | 26.26 million |
| Other Current Liabilities | 6.06 million | 998000 | N/A | 714000 | 1.05 million |
| Total Assets | N/A | 35.2 million | N/A | 38.74 million | 40.84 million |
| Common Stock | 233000 | 233000 | 233000 | 233000 | 202000 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -76.89 million | -75.92 million | -75.35 million | -71.91 million | -69.59 million |
| Other Liabilities | 7.5 million | 7.03 million | 7.02 million | 7.14 million | 7.34 million |
| Other Assets | 163000 | 161000 | 158000 | 168000 | 160000 |
| Cash | N/A | 17.61 million | N/A | 21.67 million | 23.74 million |
| Total Current Liabilities | 6.97 million | 7.53 million | N/A | 6.72 million | 7.25 million |
| Other Stockholder Equity | 1.46 million | 1.23 million | 1.9 million | 2.25 million | 1.97 million |
| Property, Plant & Equipment | 10.14 million | 10.85 million | 10.14 million | 9.74 million | 10.07 million |
| Total Current Assets | 24.08 million | 24.18 million | N/A | 28.83 million | 30.62 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 19.91 million | 20.64 million | 21.09 million | 24.22 million | 26.26 million |
| Short Term Investments | N/A | N/A | N/A | 221000 | 171000 |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | 306000 | N/A |
| Accounts Payable | 911000 | 2.06 million | N/A | 1.32 million | 1.56 million |
Brainsway Ltd (BRSYF) Chart:
Brainsway Ltd (BRSYF) News:
Below you will find a list of latest news for Brainsway Ltd (BRSYF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Brainsway Ltd (BRSYF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Brainsway Ltd (BRSYF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|